Top Medical Journal Demands More Trial Data From Drug Cos.
The British Medical Journal announced Monday that it would only publish studies by researchers and drugmakers that make patient-level clinical trial data available, joining GlaxoSmithKline PLC and European regulators in a...To view the full article, register now.
Already a subscriber? Click here to view full article